Post Content Previous Post BEL analysts raise share price target after strong FY26 guidance and expect ₹450 levels Next Post Biocon shares rise after subsidiary launches psoriasis treatment drug in Japan Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment
